# Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006)

> **NCT03778853** · PHASE4 · UNKNOWN · sponsor: **LanZhou University** · enrollment: 72 (estimated)

## Conditions studied

- Advanced Non-squamous NSCLC

## Interventions

- **DRUG:** Anlotinib Hydrochloride

## Key facts

- **NCT ID:** NCT03778853
- **Lead sponsor:** LanZhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03778853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03778853, "Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03778853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*